{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:43:04Z","timestamp":1786635784415,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Middle East Afr J Ophthalmol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0974-9233.95246","type":"journal-article","created":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T10:37:24Z","timestamp":1334918244000},"page":"185","source":"Crossref","is-referenced-by-count":21,"title":["Photodynamic therapy with verteporfin for corneal neovascularization"],"prefix":"10.4103","volume":"19","author":[{"given":"AbdullahA","family":"Al-Torbak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-9233.95246-1","first-page":"242","volume-title":"Corneal neovascularization","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0974-9233.95246-2","first-page":"2666","volume-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0974-9233.95246-3","first-page":"640","volume-title":"Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization","author":"Phillips","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0974-9233.95246-4","first-page":"920","volume-title":"Topical application of methotrexate for inhibition of corneal angiogenesis","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0974-9233.95246-5","first-page":"390","volume-title":"Photodynamic therapy with verteporfin for corneal neovascularization","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0974-9233.95246-6","first-page":"30","volume-title":"Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularzation","author":"You","year":"2011","journal-title":"Cornea"},{"key":"key-10.4103\/0974-9233.95246-7","first-page":"2148","volume-title":"Fine needle diathermy occlusion of corneal vessels","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0974-9233.95246-8","first-page":"363","volume-title":"Intravitreal bevacizumab (Avastin) for neovascular age-relatedmacular degeneration","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.95246-9","first-page":"834","volume-title":"Topical bevacizumab therapy for corneal neovascularization","author":"DeStafeno","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0974-9233.95246-10","first-page":"992","volume-title":"Subconjunctival bevacizumab for corneal neovascularization","author":"Doctor","year":"2008","journal-title":"Cornea"},{"key":"key-10.4103\/0974-9233.95246-11","first-page":"381","volume-title":"Topical bevacizumab in the treatment of corneal neovascularization: Results of a prospective, open-label, noncomparative study","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0974-9233.95246-12","first-page":"840","volume-title":"Photodynamic therapy for corneal neovascularization and lipid degeneration","author":"Brooks","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-9233.95246-13","doi-asserted-by":"crossref","unstructured":"Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 1999;117:1329-45.","DOI":"10.1001\/archopht.117.10.1329"},{"key":"key-10.4103\/0974-9233.95246-14","first-page":"215","volume-title":"Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin","author":"Yoon","year":"2006","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0974-9233.95246-15","first-page":"485","volume-title":"Photodynamic therapy of corneal neovascularization with verteporfin","author":"Fossarello","year":"2003","journal-title":"Cornea"},{"key":"key-10.4103\/0974-9233.95246-16","doi-asserted-by":"crossref","unstructured":"Veritti D, Vergallo S, Lanzetta P. Triple therapy for corneal neovascularization: A case report. Eur J Ophthalmol 2011. [In press]","DOI":"10.5301\/ejo.5000050"}],"container-title":["Middle East African Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:50:12Z","timestamp":1786632612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-9233.95246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["95246"],"URL":"https:\/\/doi.org\/10.4103\/0974-9233.95246","relation":{},"ISSN":["0974-9233"],"issn-type":[{"value":"0974-9233","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}